Pedro Kurtz1, Raimund Helbok2, Jan Claassen3, J Michael Schmidt4, Luis Fernandez5, R Morgan Stuart6, E Sander Connolly7, Kiwon Lee8, Stephan A Mayer9, Neeraj Badjatia10. 1. Neurological Intensive Care Unit, Brain Institute Paulo Niemeyer, Rio de Janeiro, Brazil. kurtzpedro@mac.com. 2. Neurological Intensive Care Unit, Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria. raimund.helbok@uki.at. 3. Division of Critical Care Neurology and Comprehensive Epilepsy Center, College of Physicians and Surgeons, Neurological Institute, Columbia University, New York, NY, USA. jc1439@columbia.edu. 4. Division of Critical Care Neurology, Neurological Institute, Columbia University College of Physicians and Surgeons, New York, NY, USA. mjs2134@columbia.edu. 5. Division of Critical Care Neurology, Neurological Institute, Columbia University College of Physicians and Surgeons, New York, NY, USA. luisfernandezmd@gmail.com. 6. Department of Neurological Surgery, Columbia University College of Physicians and Surgeons, New York, NY, USA. rms2130@columbia.edu. 7. Department of Neurological Surgery, Columbia University College of Physicians and Surgeons, New York, NY, USA. SConnolly@neuro.columbia.edu. 8. Departments of Neurology and Neurosurgery, The University of Texas Medical School at Houston, Houston, TX, USA. Kiwon.Lee@uth.tmc.edu. 9. Institute of Critical Care Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA. stephan.mayer@mountsinai.org. 10. Department of Neurology, University of Maryland School of Medicine, Baltimore, MA, USA. nbadjatia@som.umaryland.edu.
Abstract
BACKGROUND: Anemia adversely affects cerebral oxygenation and metabolism after subarachnoid hemorrhage (SAH) and is also associated with poor outcome. There is limited evidence to support the use of packed red blood cell (PRBC) transfusion to optimize brain homeostasis after SAH. The aim of this study was to investigate the effect of transfusion on cerebral oxygenation and metabolism in patients with SAH. METHODS: This was a prospective observational study in a neurological intensive care unit of a university hospital. Nineteen transfusions were studied in 15 consecutive patients with SAH that underwent multimodality monitoring (intracranial pressure, brain tissue oxygen, and cerebral microdialysis). Data were collected at baseline and for 12 h after transfusion. The relationship between hemoglobin (Hb) change and lactate/pyruvate ratio (LPR) orbrain tissue oxygen (PbtO2) was tested using univariate and multivariable analyses. RESULTS: PRBC transfusion was administered on the median post-bleed day 8. The average Hb concentration at baseline was 8.1 g/dL and increased by 2.2 g/dL after transfusion. PbtO2 increased between hours 2 and 4 post-transfusion and this increase was maintained until hour 10. LPR did not change significantly during the 12-h monitoring period. After adjusting for SpO2, cerebral perfusion pressure, and LPR, the change in Hb concentration was independently and positively associated with a change in PbtO2 (adjusted b estimate = 1.39 [95% confidence interval 0.09-2.69]; P = 0.04). No relationship between the change in Hb concentration and LPR was found. CONCLUSIONS: PRBC transfusion resulted in PbtO2 improvement without a clear effect on cerebral metabolism prior to SAH.
BACKGROUND:Anemia adversely affects cerebral oxygenation and metabolism after subarachnoid hemorrhage (SAH) and is also associated with poor outcome. There is limited evidence to support the use of packed red blood cell (PRBC) transfusion to optimize brain homeostasis after SAH. The aim of this study was to investigate the effect of transfusion on cerebral oxygenation and metabolism in patients with SAH. METHODS: This was a prospective observational study in a neurological intensive care unit of a university hospital. Nineteen transfusions were studied in 15 consecutive patients with SAH that underwent multimodality monitoring (intracranial pressure, brain tissue oxygen, and cerebral microdialysis). Data were collected at baseline and for 12 h after transfusion. The relationship between hemoglobin (Hb) change and lactate/pyruvate ratio (LPR) orbrain tissue oxygen (PbtO2) was tested using univariate and multivariable analyses. RESULTS: PRBC transfusion was administered on the median post-bleed day 8. The average Hb concentration at baseline was 8.1 g/dL and increased by 2.2 g/dL after transfusion. PbtO2 increased between hours 2 and 4 post-transfusion and this increase was maintained until hour 10. LPR did not change significantly during the 12-h monitoring period. After adjusting for SpO2, cerebral perfusion pressure, and LPR, the change in Hb concentration was independently and positively associated with a change in PbtO2 (adjusted b estimate = 1.39 [95% confidence interval 0.09-2.69]; P = 0.04). No relationship between the change in Hb concentration and LPR was found. CONCLUSIONS: PRBC transfusion resulted in PbtO2 improvement without a clear effect on cerebral metabolism prior to SAH.
Authors: Emir Festic; Alejandro A Rabinstein; William D Freeman; Elizabeth A Mauricio; Maisha T Robinson; Jay Mandrekar; Abba C Zubair; Augustine S Lee; Ognjen Gajic Journal: Neurocrit Care Date: 2013-04 Impact factor: 3.210
Authors: E Sander Connolly; Alejandro A Rabinstein; J Ricardo Carhuapoma; Colin P Derdeyn; Jacques Dion; Randall T Higashida; Brian L Hoh; Catherine J Kirkness; Andrew M Naidech; Christopher S Ogilvy; Aman B Patel; B Gregory Thompson; Paul Vespa Journal: Stroke Date: 2012-05-03 Impact factor: 7.914
Authors: Rajat Dhar; Michael T Scalfani; Allyson R Zazulia; Tom O Videen; Colin P Derdeyn; Michael N Diringer Journal: J Neurosurg Date: 2011-11-18 Impact factor: 5.115
Authors: Rajat Dhar; Allyson R Zazulia; Tom O Videen; Gregory J Zipfel; Colin P Derdeyn; Michael N Diringer Journal: Stroke Date: 2009-07-23 Impact factor: 7.914
Authors: Mauro Oddo; Andrew Milby; Isaac Chen; Suzanne Frangos; Eileen MacMurtrie; Eileen Maloney-Wilensky; Michael Stiefel; W Andrew Kofke; Joshua M Levine; Peter D Le Roux Journal: Stroke Date: 2009-03-05 Impact factor: 7.914
Authors: Joshua Levine; Andrew Kofke; Liyi Cen; Zhen Chen; Jennifer Faerber; J Paul Elliott; H Richard Winn; Peter Le Roux Journal: Neurosurgery Date: 2010-02 Impact factor: 4.654
Authors: Katja E Wartenberg; J Michael Schmidt; Jan Claassen; Richard E Temes; Jennifer A Frontera; Noeleen Ostapkovich; Augusto Parra; E Sander Connolly; Stephan A Mayer Journal: Crit Care Med Date: 2006-03 Impact factor: 7.598
Authors: Philippe Desjardins; Alexis F Turgeon; Marie-Hélène Tremblay; François Lauzier; Ryan Zarychanski; Amélie Boutin; Lynne Moore; Lauralyn A McIntyre; Shane W English; Andrea Rigamonti; Jacques Lacroix; Dean A Fergusson Journal: Crit Care Date: 2012-12-12 Impact factor: 9.097
Authors: Andreas H Kramer; Michael N Diringer; Jose I Suarez; Andrew M Naidech; Loch R Macdonald; Peter D Le Roux Journal: Crit Care Date: 2011-01-18 Impact factor: 9.097
Authors: David J Roh; David J Albers; Jessica Magid-Bernstein; Kevin Doyle; Eldad Hod; Andrew Eisenberger; Santosh Murthy; Jens Witsch; Soojin Park; Sachin Agarwal; E Sander Connolly; Mitchell S V Elkind; Jan Claassen Journal: Neurology Date: 2019-06-17 Impact factor: 9.910
Authors: Mumin Hakim; Dmitry Tumin; David P Martin; Walter Samora; Allan C Beebe; Jan E Klamar; Ashley B Hodge; Joseph D Tobias Journal: J Extra Corpor Technol Date: 2016-12
Authors: Victoria A McCredie; Simone Piva; Marlene Santos; Wei Xiong; Airton Leonardo de Oliveira Manoel; Andrea Rigamonti; Gregory M T Hare; Martin G Chapman; Andrew J Baker Journal: Neurocrit Care Date: 2017-04 Impact factor: 3.210
Authors: Andreas H Kramer; Michael N Diringer; Jose I Suarez; Andrew M Naidech; Loch R Macdonald; Peter D Le Roux Journal: Crit Care Date: 2011-01-18 Impact factor: 9.097
Authors: Shane W English; D Fergusson; M Chassé; A F Turgeon; F Lauzier; D Griesdale; A Algird; A Kramer; A Tinmouth; C Lum; J Sinclair; S Marshall; D Dowlatshahi; A Boutin; G Pagliarello; L A McIntyre Journal: BMJ Open Date: 2016-12-07 Impact factor: 2.692